Logo image
Three Doses of Vitamin D and Cognitive Outcomes in Older Women: A Double-Blind Randomized Controlled Trial
Journal article   Open access   Peer reviewed

Three Doses of Vitamin D and Cognitive Outcomes in Older Women: A Double-Blind Randomized Controlled Trial

Monica Castle, Nancy Fiedler, Lilliana Claudia Pop, Stephen J Schneider, Yvette Schlussel, Deeptha Sukumar, Lihong Hao and Sue A Shapses
The journals of gerontology. Series A, Biological sciences and medical sciences, v 75(5), pp 835-842
17 Apr 2020
PMID: 30951148
url
https://doi.org/10.1093/gerona/glz041View
Published, Version of Record (VoR)Open Access (License Unspecified) Open

Abstract

Aged Cholecalciferol - administration & dosage Cognition - drug effects Dietary Supplements Dose-Response Relationship, Drug Double-Blind Method Female Humans Memory - drug effects Middle Aged Osteocalcin - blood Parathyroid Hormone - blood Reaction Time Vitamin D - analogs & derivatives Vitamin D - blood
Vitamin D may affect cognitive performance, but previous studies are either short term or observational. We conducted a randomized controlled trial of vitamin D supplementation on domain-specific cognitive measures in postmenopausal women. Overweight/obese women with serum 25-hydroxyvitamin D (25OHD) levels less than 30 ng/mL were recruited. Vitamin D3 supplementation (600, 2,000, or 4,000 IU/d) was randomly assigned in a double-blinded manner for 1 year. Serum 25-hydroxyvitamin D, osteocalcin (total and undercarboxylated), amyloid beta, parathyroid hormone, and estradiol were analyzed before and after supplementation. Cognitive tests were administered after treatment. The women (58 ± 6 years; body mass index, 30.0 ± 3.5 kg/m2) had a baseline serum 25-hydroxyvitamin D level of 22.6 ± 5.8 ng/mL that increased to 30.2 ± 5.6, 36.0 ± 4.9, and 40.8 ± 7.0 ng/mL in the 600, 2,000, and 4,000 IU/d groups, respectively (p < .001). Participants taking 2,000 IU/d compared to other doses performed better in learning and memory tests (p < .05), yet the 4,000 IU/d group had a slower reaction time compared to the 600 IU/d group. Multiple regression indicated that serum undercarboxylated osteocalcin predicted tasks associated with reaction time and executive function, whereas body mass index and parathyroid hormone negatively predicted reaction time and executive function (p ≤ .01). These data suggest that vitamin D has differential effects on domain-specific cognitive measures and that a higher dose may negatively affect reaction time.

Metrics

9 Record Views
34 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Geriatrics & Gerontology
Gerontology
Logo image